--- title: "TransMedics 集團調查啓動：Kahn Swick & Foti, LLC 對 TransMedics 集團公司的高管和董事進行調查 - TMDX" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/296122272.md" description: "Kahn Swick & Foti, LLC 已對 TransMedics Group, Inc. (TMDX) 發起調查，涉及其高管和董事可能違反信託責任或違反州和聯邦法律的情況。這一調查是基於 Scorpion Capital 的報告，該報告指控存在欺詐性賬單和其他不當行為，這導致對該公司及某些高管提起了正在進行的證券集體訴訟" datetime: "2026-08-17T14:39:41.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296122272.md) - [en](https://longbridge.com/en/news/296122272.md) - [zh-HK](https://longbridge.com/zh-HK/news/296122272.md) generator: "portal-rs" --- # TransMedics 集團調查啓動：Kahn Swick & Foti, LLC 對 TransMedics 集團公司的高管和董事進行調查 - TMDX TransMedics Group Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of TransMedics Group, Inc. - TMDX Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into TransMedics Group, Inc. (NasdaqGM: TMDX) (“TransMedics” or the “Company”). TransMedics is a medical technology company focused on transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure. The Company operates the Organ Care System, or OCS, and the National OCS Program, or NOP. On January 10, Scorpion Capital released a report alleging that, based on a “6-month investigation with over 30 interviews, including ex-employees, surgeons, leading transplant centers, organ procurement organizations, competitors, and its largest customers,” the Company had engaged in fraudulent billing, coercive business practices, and unsafe organ transplantation, as well as extortion, racketeering, and organ trafficking under the guise of a medical device company. Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period in violation of federal securities laws, which remains ongoing. KSF’s investigation is focusing on whether TransMedics’ officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws. If you have information that would assist KSF in its investigation, or have been a long-term holder of TransMedics shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-833-538-3606 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nasdaqgm-tmdx/ to learn more. About Kahn Swick & Foti, LLC KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg. TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services To learn more about KSF, you may visit www.ksfcounsel.com. CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn Kahn Swick & Foti, LLC Lewis Kahn, Managing Partner lewis.kahn@ksfcounsel.com 1-833-538-3606 1100 Poydras St., Suite 960 New Orleans, LA 70163 View source version on businesswire.com: https://www.businesswire.com/news/home/20260817649788/en/ ### 相關股票 - [TMDX.US](https://longbridge.com/zh-HK/quote/TMDX.US.md) ## 相關資訊與研究 - [TransMedics 重申其 2026 年收入預期為 7.37 億美元至 7.57 億美元](https://longbridge.com/zh-HK/news/298638704.md) - [TransMedics 任命 Fernando Araujo 為首席財務官，並重申其 2026 年財務展望](https://longbridge.com/zh-HK/news/298638305.md) - [TransMedics 任命 Fernando Araujo 為首席財務官，該任命自 9 月 21 日起生效](https://longbridge.com/zh-HK/news/298642921.md) - [Legal & General Group Plc 投資 529 萬美元於 TransMedics Group, Inc.（股票代碼：TMDX）](https://longbridge.com/zh-HK/news/298014362.md) - [Algert Global LLC 購買了 31,710 股 TransMedics Group, Inc.（股票代碼：TMDX）的股票](https://longbridge.com/zh-HK/news/297392700.md) --- > **免責聲明: 本文僅供參考，不構成任何投資建議。**